Income related inequality in prescription drugs in Denmark

Pharmacoepidemiology and Drug Safety

Volumn 14, Issue 5, 2005, Pages 307-317

  Gundgaard, Jens ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Concentration index; Inequality; Inequity; Prescription database; Prescription drugs; Standardisation; Utilisation

Indexed keywords

ARTICLE; DATA BASE; DENMARK; DRUG UTILIZATION; HEALTH STATUS; HEALTH SURVEY; HUMAN; INCOME; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; PRIORITY JOURNAL; REIMBURSEMENT; SOCIOECONOMICS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DENMARK; DRUG UTILIZATION; FEMALE; FINANCING, GOVERNMENT; FINANCING, PERSONAL; HUMANS; MALE; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; PRESCRIPTION FEES; PRESCRIPTIONS, DRUG; SOCIOECONOMIC FACTORS;

EID: 19144366617     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/pds.1039     Document Type: Article

References (34)

1. The Copenhagen declaration on reducing social inequalities in health. Scand J Public Health 2002; 59: 78-79.
2. Dahlgren G, Whitehead M. Policies and strategies to promote equity in health. 1-50. 2000. Copenhagen, WHO Regional Office for Europe.
3. Stronks G, Gunning-Schepers LJ. Should equity in health be target number 1. Eur J Public Health 65: 153-165.
4. Clarke PM, Gerdtham UG, Connelly LB. A note on the decomposition of the health concentration index. Health Econ 2003; 12: 511-516.
5. Humphries KH, van Doorslaer E. Income-retated health inequality in Canada. Soc Sci Med 2000; 50: 663-671.
6. Kakwani N, Wagstaff A, van Doorslaer E. Socioeconomic inequalities in health: measurement, computation, and statistical inference. J Econometrics 1997; 77: 87-103.
7. van Doorslaer E, Wagstaff A, Bleichrodt H, et al. Income-related inequalities in health: some international comparisons. J Health Econ 1997; 16: 93-112.
8. van Doorslaer E, Wagstaff A, van der BH, et al. Equity in the delivery of health care in Europe and the US. J Health Econ 2000; 19: 553-583.
9. van Doorslaer E, Masseria C, the OECD Health Equity Research Group Members. Income-related inequality in the use of medical care in 21 OECD countries. 14. 2004. Paris, OECD. OECD Health Working Papers.
10. Koolman X, van Doorslaer E. On the interpretation of a concentration index of inequality. Health Econ 2004; 13: 649-656.
11. The Danish Medicines Agency. Medicinal product statistics 1997-2001. 2002. Schultz Information.
12. Ministry of Interior and Health. [The Health Care Sector in Numbers]. 2002. Statens Information.
13. Christiansen T, Enemark U, Clausen J, et al. Health care and cost containment in Denmark. In Health Care and Cost Containment in the European Union, Mossialos E, Le Grand J (eds). Ashgate 1999; 267.
14. Henricson K, Stenberg P, Rametsteiner G, Ranstam J, Hanson BS, Melander A. Socioeconomic factors, morbidity and drug utilization - an ecological study. Pharmacoepidemiol Drug Safe 1998; 7: 261-267.
15. Metge C, Black C, Peterson S, Kozyrskyj AL. The population's use of pharmaceuticals. Med Care 1999; 37: JS42-JS59.
16. Lexchin J. Income class and pharmaceutical expenditure in Canada: 1964-1990. Can J Public Health 1996; 87: 46-50.
17. Eggen AE. Pattern of drug use in a general population - prevalence and predicting factors: the Tromso study. Int J Epidemiol 1994; 23: 1262-1272.
18. Furu K, Straume B, Thelle DS. Legal drug use in a general population: association with gender, morbidity, health care utilization, and lifestyle characteristics. J Clin Epidemiol 1997; 50: 341-349.
19. van der Meer JB, van den BJ, Mackenbach JP. Socioeconomic differences in the utilization of health services in a Dutch population: the contribution of health status. Health Policy 1996; 37: 1-18.
20. Kjøller M, Rasmussen NK. Danish Health and Morbidity Survey 2000... & trends since 1989. 2002. National Institute of Public Health.
21. Christiansen T. Equity in the Delivery of Health Care in Denmark. CHS Working Paper. University of Southern Denmark 1997; 10.
22. Gundgaard J, Sørensen J. [Evaluation of the Prevention Strategy in Funen County: Baseline Survey on Behaviour with respect to Tobacco, Alcohol, Diet and Exercise]. 2002. Funen County.
23. Hallas J, Nissen A. Individualized drug utilization statistics: analysing a population's drug use from the perspective of individual users. Eur J Clin Pharmacol 1994; 47: 367-372.
24. Hallas J. Conducting pharmacoepidemiologic research in Denmark. Pharmacoepidemiol Drug Safe 2001; 10: 619-623.
25. Brooks R. EuroQol: the current state of play. Health Policy 1996; 37: 53-72.
26. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997; 35: 1095-1108.
27. The EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990; 16: 199-208.
28. Wittrup-Jensen KU, Lauridsen J, Gudex C, Brooks R, Pedersen KM. Danish EuroQol tariffs estimated by the Visual Analogue Scale (VAS) and the Time Trade-Off (TTO). Paper presented at the 6th EuroQol Group Meeting in Copenhagen, 6n September 2001. Not yet published 2001.
29. Lipscomb J, Ancukiewicz M, Parmigiani G, Hasselblad V, Samsa G, Matchar DB. Predicting the cost of illness: a comparison of alternative models applied to stroke. Med Decis Making 1998; 18: S39-S56.
30. Manning WG. The logged dependent variable, heteroscedasticity, and the retransformation problem. J Health Econ 1998; 17: 283-295.
31. Andersen CK, Andersen K, Kragh-Sorensen P. Cost function estimation: the choice of a model to apply to dementia. Health Economics 2000; 9: 397-409.
32. Mackenbach JP, Kunst AE. Measuring the magnitude of socioeconomic inequalities in health: an overview of available measures illustrated with two examples from Europe. Soc Sci Med 1997; 44: 757-771.
33. Wagstaff A, Paci P, van Doorslaer E. On the measurement of inequalities in health. Soc Sci Med 1991; 33: 545-557.
34. Van der Heyden JH, Demarest S, Tafforeau J, Van Oyen H. Socio-economic differences in the utilisation of health services in Belgium. Health Policy 2003; 65: 153-165.